Breast Cancer Decision-Making

Eike Nohdurft, Elisa F. Long, Stefan Spinler
Decision Analysis (forthcoming), 2017 
Elisa F. Long, Patricia A. Ganz
JAMA Oncology, 2015, Sep:1-2

Hospital Operations

Elisa F. Long, Kusum S. Mathews
Under review, 2017 
Kusum S. Mathews, Elisa F. Long
Annals of the American Thoracic Society, 2015, 12(6):886-894

Infectious Disease Resource Allocation

Spatial Resource Allocation for Emerging Epidemics: A Comparison of Greedy, Myopic, and Dynamic Polices  [Appendix]

Elisa F. Long, Eike Nohdurft, Stefan Spinler
Major revision, Manufacturing & Service Operations Management, 2017

Sabina S. Alistar, Elisa F. Long, Margaret L. Brandeau, Eduard J. Beck
Health Care Management Science, 2014, 17(2):162-181
Elisa F. Long, Margaret L. Brandeau
In Tutorials in Operations Research, Paul Gray (Ed.), Institute for Operations Research and Management Sciences (INFORMS), 2009

Controlling Co-epidemics: Analysis of HIV and Tuberculosis Infection Dynamics   [Appendix]

Elisa F. Long, Naveen K. Vaidya, Margaret L. Brandeau
Operations Research, 2008, 56(6):1366-81

HIV Screening and Prevention

Dahye L. Song, Frederick L. Altice, Michael M. Copenhaver, Elisa F. Long
PLoS ONE, 2015, 10(2):e0116694

Expanded HIV Testing in Low-Prevalence, High-Income Countries: A Cost-Effectiveness Analysis for the United Kingdom   [Appendix]

Elisa F. Long, Roshni Mandalia, Sundhiya Mandalia, Sabina S. Alistar, Eduard J. Beck, Margaret L. Brandeau
PLoS ONE, 2014, 9(4):e95735
Elisa F. Long, Douglas K. Owens
Vaccine, 2011, 29(36):6113-24

HIV Screening via Fourth-Generation Immunoassay or Nucleic Acid Amplification Test in the United States: A Cost-Effectiveness Analysis  [Appendix]

Elisa F. Long
PLoS ONE, 2011, 6(11):1-10

The Cost-Effectiveness of Symptom-Based Testing and Routine Screening for Acute HIV Infection in Men Who Have Sex with Men in the United States  [Appendix]

Jessie L. Juusola, Margaret L. Brandeau, Elisa F. Long, Douglas K. Owens, Eran Bendavid
AIDS, 2011, 24(14):1779-87

The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States  [Appendix]

Elisa F. Long, Margaret L. Brandeau, Douglas K. Owens
Annals of Internal Medicine, 2010, 153(12):778-89

Potential Population Health Outcomes and Expenditures of HIV Vaccination Strategies in the United States  [Appendix]

Elisa F. Long, Margaret L. Brandeau, Douglas K. Owens
Vaccine, 2009, 27(39):5402-10

Epidemic Modeling in Resource-Limited Settings

The Complex Interplay of Social Networks, Geography and HIV Risk among Malaysian Drug Injectors: Results from Respondent-Driven Sampling 

Alexei Zelenev, Elisa F. Long, Alexander R. Bazazi, Adeeba Kamarulzaman, Frederick L. Altice
International Journal of Drug Policy, 2016, 37:98-106

Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa  [Appendix]

Jennifer A. Gilbert, Elisa F. Long, Ralph P. Brooks, Gerald H. Friedland, Anthony P. Moll, Jeffrey P. Townsend, Alison P. Galvani, Sheela V. Shenoi
PLoS ONE, 2015, 10(5):e0126267

Cost Effectiveness of Option B Plus for Prevention of Mother-to-Child Transmission of HIV in Resource-Limited Countries: Evidence from Kumasi, Ghana  [Appendix]

Adam VanDeusen, Elijah Paintsil, Thomas Agyarko-Poku, Elisa F. Long
BMC Infectious Diseases, 2015, 15(130):1-10

Portfolios of Biomedical HIV Interventions in South Africa: A Cost-Effectiveness Analysis  [Appendix]

Elisa F. Long, Robert R. Stavert
Journal of General Internal Medicine, 2013, 28(10):1294-301

HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa 

Jeffrey W. Eaton, Leigh F. Johnson, Joshua A. Salomon, Till Bärnighausen, Eran Bendavid, Anna Bershteyn, David E. Bloom, Valentina Cambiano, Christophe Fraser, 
Jan A. C. Hontelez, Salal Humair, Daniel J. Klein, Elisa F. Long, Andrew N. Phillips, Carel Pretorius, John Stover, Edward A. Wenger, Brian G. Williams, Timothy B. Hallett
PLoS Medicine, 2012, 9(7):e1001245

Optimal Spending on HIV Prevention and Treatment: A Framework for Evaluating the Cost-Effectiveness of HIV Prevention and Treatment Programs with Example Application to the India AIDS Initiative

Margaret L. Brandeau, Elisa F. Long, David W. Hutton, Douglas K. Owens
In Optimization in Medicine and Biology, Gino J. Lim and Eva K. Lee (Eds.), Taylor and Francis Publishers, 2008

Effectiveness and Cost-Effectiveness of Strategies to Expand Antiretroviral Therapy in St. Petersburg, Russia  [Appendix]  [Russian Translation]

Elisa F. Long, Margaret L. Brandeau, Cristina M. Galvin, Tatyana Vinichenko, Swati P. Tole, Adam Schwartz, Gillian D. Sanders, Douglas K. Owens
AIDS, 2006, 20:2207-15

Cost-Effectiveness of Medical Technologies

Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure  [Appendix]

Elisa F. Long, Gary W. Swain, Abeel A. Mangi
Circulation: Heart Failure, 2014, 7(3):470-8 

Cost-Effectiveness of Elective Induction of Labor at 41 Weeks in Nulliparous Women 

Anjali J. Kaimal, Sarah E. Little, Anthony O. Odibo, David M. Stamilio, William A. Grobman, Elisa F. Long, Douglas K. Owens, Aaron B. Caughey
American Journal of Obstetrics and Gynecology, 2011, 204(2):137.e1-e9

Cost-Effectiveness Analysis of Mechanical Thrombectomy in Acute Ischemic Stroke 

Chirag G. Patil, Elisa F. Long, Maarten G. Lansberg
Journal of Neurosurgery, 2009, 110(3):508-13